• 1
    Gloor, P. Mesial temporal sclerosis: historical background and an overview from a modern perspective. In: LudersH, ed. Epilepsy surgery. New York: Raven Press, 1991: 689703.
  • 2
    Bouchet C. De l'épilepsie considérée dans ses rapports avec l'aliénation mentale: recherche sur la nature et le siége de ces deux maladies. Arch Gén Méd 1825;9: 51042.
  • 3
    Sommer W. Erkrankung des Ammonshorns als aetiologisches Moment der Epilepsie. Arch Psychiatr Nervenkr 1880;10: 63175.
  • 4
    Lorente de Nó R. Studies on the structure of the cerebral cortex, II: continuation of the study of the ammonic system. J Psychol Neurol (Leipzig) 1934;46: 11377.
  • 5
    Bratz E. Ammonshornbefunde bei Epileptikern. Arch Psychiatr Nervenkr 1899;32: 82035.
  • 6
    Meencke HJ, Veith G. Hippocampal sclerosis in epilepsy. In: LudersHO, ed. Epilepsy surgery. New York: Raven Press, 1991: 70515.
  • 7
    Mouritzen Dam A. Epilepsy and neuron loss in the hippocampus. Epilepsia 1980;21: 61729.
  • 8
    Babb TL, Brown WJ, Pretorius J, et al. Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia 1984;25: 72940.
  • 9
    Sagar HJ, Oxbury JM. Hippocampal neuronal loss in temporal lobe epilepsy: correlation with early childhood convulsions. Ann Neurol 1987;22: 33440.
  • 10
    Kim JH, Guimaraes PO, Shen M-Y, et al. Hippocampal neuronal density in temporal lobe epilepsy with and without gliomas. Acta Neuropathol 1990;80: 415.
  • 11
    Mathern GW, Kuhlman PA, Mendoza D, et al. Human fascia dentata and hippocampal neuron densities differ depending on the epileptic syndrome and age at first seizure. J Neuropathol Exp Neurol 1997;56: 199212.
  • 12
    Bruton CJ. The neuropathology of temporal lobe epilepsy. Oxford: Oxford University Press, 1988.
  • 13
    Babb TL. Research on the anatomy and pathology of epileptic tissue. In: LüdersHO, eds. Epilepsy surgery. New York: Raven Press, 1991: 71927.
  • 14
    Kim JH. Pathology of epilepsy. Exp Mol Pathol 2001;70: 34567.
  • 15
    De Lanerolle NC. The pathology of the epilepsies: insights from pathology to mechanisms of causation of temporal lobe epilepsy. In: PellockJM, BourgeoisWED, eds. Pediatric epilepsy: diagnosis and therapy. New York: Demos, 2001: 4560.
  • 16
    De Lanerolle NC, Kim JH, Brines ML. Cellular and molecular alterations in partial epilepsy. Clin Neurosci 1994;2: 6481.
  • 17
    De Lanerolle NC, Williamson A, Meredith C, et al. Dynorphin and the kappa 1 ligand [3H]-U69,539 binding in the human epileptogenic hippocampus. Epilepsy Res 1997;28: 189205.
  • 18
    Williamson A. Electrophysiology of epileptic human neocortical and hippocampal neurons maintained in vitro. Clin Neurosci 1994;2: 4752.
  • 19
    Spencer DD, Spencer SS, Mattson RH, et al. Access to posterior medial temporal lobe structures in the surgical treatment of temporal lobe epilepsy. Neurosurgery 1984;15: 66771.
  • 20
    Spencer DD, Spencer SS. Surgery for epilepsy. Neurol Clin 1985;3: 31330.
  • 21
    De Lanerolle NC, Kim JH, Robbins RJ, et al. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 1989;495: 38795.
  • 22
    Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 1946;94: 23947.
  • 23
    Gundersen HJ. The new stereological tools. APMIS 1988;96: 37994;857–81.
  • 24
    Sternberger LA. Immunocytochemistry. New York: John Wiley & Sons, 1986.
  • 25
    Hsu S, Raine L, Fanger H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29: 57780.
  • 26
    Williamson A, Spencer SS, Spencer DD. Depth electrode studies and intracellular dentate granule cell recordings in temporal lobe epilepsy. Ann Neurol 1995;38: 77887.
  • 27
    Siegel S. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill, 1956.
  • 28
    Mathern GW, Babb TL, Armstrong DL. Hippocampal sclerosis. In: EngelJ, PedleyTA, eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997: 13555.
  • 29
    Kim JH. Pathology of seizure disorders. Neuroimag Clin North Am 1995;5: 52745.
  • 30
    Engel JJ. Outcome with respect to epileptic seizures. In: EngelJJr., ed. Surgical treatment of epilepsy. New York: Raven Press, 1987: 55372.
  • 31
    Kim RB, Williamson A, Kim JH, et al. Paradoxical temporal lobe epilepsy: clinical, radiographic, pathologic, immunohistochemical and electrophysiologic features. Epilepsia 1998;39(suppl 6):69.
  • 32
    Zaveri HP, Duckrow RB, De Lanerolle NC, et al. Distinguishing subtypes of temporal lobe epilepsy with background hippocampal activity. Epilepsia 2001;42: 72530.
  • 33
    Sloviter RS. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 1987;235: 736.
  • 34
    Patrylo PR, Van den Pol AN, Spencer DD, et al. NPY inhibits glutamatergic excitation in the epileptic human dentate gyrus. J Neurophysiol 1999;82: 47883.
  • 35
    O'Connor ER, Sontheimer H, Spencer DD, et al. Astrocytes from human hippocampal epileptogenic foci exhibit action potential-like responses. Epilepsia 1998;39: 34754.
  • 36
    Herkenham M. The connections of the nucleus reuniens thalami: evidence for a direct thalamohippocampal pathway in the rat. J Comp Neurol 1978;177: 589610.
  • 37
    Yanagihara M, Niimi K, Ono K. Thalamic projections to the hippocampal and entorhinal areas in the cat. J Comp Neurol 1987;266: 12241.
  • 38
    Spencer DD, Spencer SS, Mattson RH, et al. Intracerebral masses in patients with intractable partial epilepsy. Neurology 1984;34: 4326.
  • 39
    Wolf HK, Roos D, Blümcke I, et al. Perilesional neurochemical changes in focal epilepsies. Acta Neuropathol 1996;91: 37684.